semaglutide side effects sweating Does GLP-1 Cause Night Sweats? FDA Data and Facts Who should not take semaglutide?

The gap between positive and negative experiences is wide and consistent, suggesting significant variability in fulfillment and product quality across batches and time periods.

It is a prescription-only medication that requires approval from a licensed healthcare provider

For obesity management, semaglutide is initiated at 0.25 mg weekly and titrated gradually to the target dose of 2.4 mg weekly to minimize gastrointestinal intolerance[14]

Sin embargo, personas que no tienen diabetes ni obesidad estn consumiendo el medicamento para bajar de peso de forma rpida, un hbito que preocupa a los mdicos y cientficos

Parte del entusiasmo por este nuevo agente fue la impresionante prdida de peso que demostr en el programa clnico Efecto del tratamiento con semaglutida en personas con obesidad (STEP), que respalda su aprobacin por la FDA